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Treatment Outcome of Infections Associated 
with Internal Fixation Devices: Results from a 
5-year Retrospective Study (1999-2003) 
A. Trampuz ~ *, A. Gilomen 1, U. Fluckiger ~, R. Frei ~ ,
W. Zimmerli 2, A. Widmer ~. IUniversity Hospital, 
Basel, Switzerland, 2Kantonsspital, Liestal, 
Switzerland 
Background: Infections associated with orthopedic 
devices are difficult to treat and cause significant 
morbidity. Data about treatment outcome are lim- 
ited. 
Objective: To evaluate characteristics and treat- 
ment outcome of infections associated with inter- 
hal fixation devices over a 5-year period. 
Methods: We reviewed patient records from all 
patients admitted to the University Hospital Basel 
from 1/1999 through 12/2003 because of an in- 
ternal fixation device-associated infection, defined 
as growth of the same microorganism in >1 tis- 
sue culture, visible purulence, sinus tract or acute 
inflammation on tissue histopathology. Patients, 
their relatives and/or physicians were contacted 
to determine the outcome. 
Results: We reviewed 132 consecutive patients 
with a device-associated infection, involving lower 
extremity (n=54), foot (n=31) upper extrem- 
ity (n=21), spine (n=11) and other locations 
(n= 15). The median age was 74y (range, 16-96y); 
53% were men. Median hospital stay was 25d 
(range, 1-175 d). Debridement with retention was 
performed in 70 patients (54%), device removal 
in 57 patients (44%) and 3 patients (2%) had 
no surgery. In 37 patients (28%) more than one 
pathogen was isolated; most common pathogens 
were S. aureus (35%), coagulase-negative staphy- 
lococci (27%), streptococci (6%), enterococci (9%), 
Gram-negative rods (17%) and anaerobes (6%). At 
admission, fever was present in 19%, joint pain 
in 51%, swelling in 42%, erythema in 51%, 
warmth 14%, sinus tract in 34%. Patients were 
followed for a median of 2.4 y (range, 34 d to 6.3 y), 
9 patients died (2 of them related to the device- 
associated infection) and 18 (14%) were lost to 
follow-up. Of the remaining 105 patients, 92 (88%) 
had a successful outcome after >1 year: 86% with 
debridement and retention and 91% with device 
removal. 
Conclusions: A subset of patients with infected 
fixation devices can be successfully treated by de- 
bridement and antimicrobial therapy. 
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Background: Prosthetic joint infections (PJI) lead 
to significant long-term morbidity with high cost 
of care. Since 1988, patients with PJI have been 
treated at our hospital according to a standardized 
algorithm (NEJM 2004; 351: 1645). We evaluated 
characteristics of PJI over a 10-year period. 
Objective: To evaluate characteristics and treat- 
ment outcome of PJI over a 10-year period. 
Methods: All patients hospitalized at our institu- 
tion from 1/1994 to 12/2003 with PJI (defined as 
growth of the same microorganism in ~>2 tissue or 
synovial fluid cultures, visible purulence, sinus 
tract or acute inflammation on tissue histopathol- 
ogy) were included. Patients, their relatives and/or 
treating physicians were contacted to determine 
the outcome. 
Results: 129 patients with PJI were identified; 
for 119 (92%) data were available, involving 
hip (78), knee (22), ankle (11) and shoulder pros- 
theses. The median age was 73y (range, 33-94y); 
52% were men. Median hospital stay was 27d 
(range, 1-125d); 12 patients (10%) needed inten- 
sive care. Most common reason for primary arthro- 
plasty was trauma (42%) and osteoarthritis (30%). 
Debridement with retention was performed in 
80 (67%), one-stage xchange in 15 (13%), two- 
stage exchange in 15 (13%) and prosthesis removal 
in 6 (5%); 3 patients (2%) had no surgery. Iso- 
lated pathogens were S. aureus (37%), coagulase- 
negative staphylococci (34%), streptococci (7%), 
enterococci (3%), Gram-negative rods (11%) and 
anaerobes (8%). In 23 episodes (19%) more than 
one pathogen was found. Patients were followed 
for a median of 3.1 years, 11 patients (9%) died 
(all unrelated to PJI) and 15 (13%) were lost to 
follow-up. Of the remaining 93 patients, 84 (90%) 
had a successful outcome after ~>2 years: 91% with 
debridement and retention, 89% with one-stage 
exchange, 80% two-stage xchange and 83% with 
prosthesis removal. 
Conclusions: Using a standardized algorithm for 
treatment of PJI had an overall success rate of 90% 
after ~>2 years. Cure rate of PJI with debridement 
and retention in appropriately selected patients 
was 91%. 
